BioAccel

BioAccel is an independent, non-profit organization established in Phoenix, Arizona in 2009. It focuses on accelerating the development of early-stage life science technologies by providing funding and business expertise. BioAccel aims to bridge the 'Valley of Death' gap, fostering new companies and biomedical products that ultimately benefit the public.

MaryAnn Guerra

Co-Founder, Chairman of the Board

Past deals in Arizona

Life365

Seed Round in 2017
Life365, Inc. is a Scottsdale, Arizona-based company that specializes in a virtual care and remote patient monitoring platform aimed at enhancing patient management outside traditional healthcare settings. Established in 2015, Life365 offers a range of products, including bundled health kits that feature pre-paired and pre-configured smart devices, designed to facilitate patient engagement and adherence to health protocols. The platform integrates various connected solutions, allowing healthcare providers to proactively manage patient health conditions and reduce costly healthcare utilization. Life365 has formed strategic partnerships, including collaborations with Microsoft Cloud for Healthcare, enabling integration with numerous health systems and streamlining service deployment. The company’s innovations have earned recognition, including the 2021 Edison Award for COVID-19 solutions and a spot among the Top 50 Remote Monitoring Companies by AVIA in 2022. With a robust patent portfolio, Life365 is positioned to continue expanding its offerings in virtual care, supporting both providers and patients in the transition to home-based healthcare management.

Omni Bioceutical Innovations

Non Equity Assistance in 2015
Omni Bioceutical Innovations, Inc. is a manufacturer of skin and hair treatment solutions designed to address various dermatological and anti-aging needs. Founded in 2014 and headquartered in Phoenix, Arizona, the company develops products such as anti-aging serums, scar reduction therapies, and hair regrowth supports, utilizing scientifically proven ingredients like growth factor proteins, amino acids, and peptides. These formulations promote collagen and elastin production, enhancing skin rejuvenation and hair health. Omni Bioceutical Innovations serves professionals in the global medical aesthetic market, offering innovative solutions that cater to the lifelong dermatological requirements of individuals. The company's commitment to quality is supported by collaborations with leading scientists and physicians in the field.

Hildeez Enterprises

Non Equity Assistance in 2015
Hildeez Enterprises is a manufacturer of post-surgical recovery garments intended for patients who undergo surgical procedures of the knee, hip, or shoulder. The recovery garments provide modesty for patients in a hospital setting instead of having to 'bear it all' using the traditional gowns. The company was founded in 2010 and based in Peoria, Arizona.

RightBio Metrics

Non Equity Assistance in 2015
RightBio Metrics develops fluid measurement technologies for healthcare providers, offering non-invasive devices and pH-based indicators to verify tube placement and assess gastric acidity, thereby guiding critical treatment decisions. Its products include RightpH, RightSpot, RightLevel, and RightSpot Infant, which enable clinicians to confirm gastric contents and reduce misplacement risk for feeding and suction tubes. Founded in 2005 and based in Scottsdale, Arizona, the company emphasizes safe, accurate bedside measurements and closed systems. The RightSpotpH Indicator is FDA-cleared and CLIA-waived for use across neonates to adults, providing a gastric-acidity test to support proper tube verification without exposure to aspirates. Through its technologies, RightBio Metrics seeks to enhance patient safety and care quality by delivering reliable, easy-to-use measurement tools for clinical decision-making.

Arizona Medical Systems

Non Equity Assistance in 2015
Arizona Medical Systems, LLC (AMS) is a medical device company founded through a partnership involving Dr. Richard Heuser, MediCoventures, and BioAccel. The company focuses on developing innovative technologies that simplify medical procedures, particularly in the field of vascular access. Its flagship product, the Punctual Guidewire™, is specifically designed to facilitate rapid vascular access, improving both the efficiency of procedures for physicians and patient outcomes. By addressing issues related to waste, cost, and blood loss during interventional procedures, AMS aims to enhance the capabilities of medical practitioners and meet the increasing demand for advanced cardiovascular technologies.

Nasseo

Non Equity Assistance in 2015
Nasseo, Inc. is a medical device company based in Peoria, Arizona, that specializes in the development and manufacturing of dental and orthopedic implant systems. Founded in 2012, Nasseo has pioneered a next-generation nanotube implant surface technology known as TiArray, which enhances the performance of implants for patients with poor circulatory issues, such as diabetics and smokers. This innovative technology modifies the natural oxide layer of implant materials, resulting in a uniform nanotube array that promotes stronger bonding, faster healing, and improved tissue response. Nasseo's flagship product, the TiArray Dental Implant, has received FDA approval, and the company plans to conduct post-market human clinical trials. Additionally, Nasseo is working on a Titanium-PEEK hybrid interbody fusion device that will also incorporate its advanced TiArray technology, further expanding its product offerings in the field of implantable medical devices.

Nasseo

Seed Round in 2013
Nasseo, Inc. is a medical device company based in Peoria, Arizona, that specializes in the development and manufacturing of dental and orthopedic implant systems. Founded in 2012, Nasseo has pioneered a next-generation nanotube implant surface technology known as TiArray, which enhances the performance of implants for patients with poor circulatory issues, such as diabetics and smokers. This innovative technology modifies the natural oxide layer of implant materials, resulting in a uniform nanotube array that promotes stronger bonding, faster healing, and improved tissue response. Nasseo's flagship product, the TiArray Dental Implant, has received FDA approval, and the company plans to conduct post-market human clinical trials. Additionally, Nasseo is working on a Titanium-PEEK hybrid interbody fusion device that will also incorporate its advanced TiArray technology, further expanding its product offerings in the field of implantable medical devices.

Stimwave

Non Equity Assistance in 2012
Stimwave Technologies, Inc., established in 2010, is a medical device company based in Scottsdale, Arizona. It specializes in the development, manufacturing, and marketing of wireless, microsize injectable medical devices for neurology markets. The company's flagship product, the Freedom SCS System, is a spinal cord stimulator used to alleviate chronic low back and leg pain. Additionally, Stimwave offers the StimQ PNS System, a peripheral nerve stimulator that targets specific nerves to treat chronic pain. Both products utilize the company's proprietary MicroStim wireless technology. Stimwave operates under the name Stimwave Technologies, Inc., following a rebrand from its former name, Neural Micro Incorporated.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.